Publication | Open Access

Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents

Medicinal ChemistryAnti-inflammatory AgentsBiochemistryMedicineNatural SciencesMechanism Of ActionPharmacological AgentPharmacotherapyDrug DevelopmentPharmacologySilico StudiesPharmaceutical ChemistryVitro EvaluationDrug Discovery